{
    "patient": {
        "Name": "Charles Turner",
        "DateOfBirth": "1972-09-21",
        "Sex": "Male",
        "Diagnosis": "Medullary thyroid cancer",
        "BodyPart": "Thyroid",
        "Physician": "Dr. Rebecca Flynn",
        "TreatingInstitution": "Fletcher PLC"
    },
    "specimen": {
        "Tumor specimen": {
            "source": "Thyroid",
            "CollectedDate": "2023-04-28",
            "ReceivedDate": "2023-04-29",
            "TumorPercentage": "68%"
        },
        "Normal specimen": {
            "source": "Blood",
            "CollectedDate": "2023-05-04",
            "ReceivedDate": "2023-05-06"
        }
    },
    "genomic variants": {
        "Somatic - Potentially Actionable": [
            {
                "Gene": "PDGFRB",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.T681I Frameshift-GOF",
                "VariantAlleleFraction": "22.86%"
            },
            {
                "Gene": "CCND3",
                "DNA Alteration": "c.766_776del11",
                "GeneMutation": "p.R256fs*64 Nonsense-GOF",
                "VariantAlleleFraction": "5.48%"
            }
        ],
        "Somatic - Biologically Relevant": [
            {
                "Gene": "ERBB2",
                "DNA Alteration": "c.2584A>G",
                "GeneMutation": "p.R896C Spliceregionvariant-LOF",
                "VariantAlleleFraction": "1.03%"
            },
            {
                "Gene": "MAPK1",
                "DNA Alteration": "c.964G>A",
                "GeneMutation": "p.L755P Nonsense-LOF",
                "VariantAlleleFraction": "6.25%"
            },
            {
                "Gene": "CDC73",
                "DNA Alteration": "c.1A>G",
                "GeneMutation": "p.L755S Nonsense-GOF",
                "VariantAlleleFraction": "10.39%"
            },
            {
                "Gene": "SDHA",
                "DNA Alteration": "c.1660C>T",
                "GeneMutation": "p.R256fs*64 Frameshift-GOF",
                "VariantAlleleFraction": "13.38%"
            },
            {
                "Gene": "ABL1",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.G660D Missensevariant(exon2)-GOF",
                "VariantAlleleFraction": "7.63%"
            },
            {
                "Gene": "KRAS",
                "DNA Alteration": "c.36T>C",
                "GeneMutation": "p.G12C Nonsense-GOF",
                "VariantAlleleFraction": "4.59%"
            }
        ],
        "Germline - Pathogenic": [],
        "Pertinent Negatives": [
            "SRSF2",
            "PAX5",
            "CCND3",
            "HDAC2",
            "PDGFRA"
        ]
    },
    "immunotherapy markers": [
        {
            "marker_name": "Tumor Mutational Burden",
            "TmbValue": "40 m/Mb",
            "Tmbpercentile": "97%",
            "Status type": "Microsatellite Instability Status",
            "statusvalue": "Stable"
        }
    ],
    "FDA-Approved Therapies": {
        "Current Diagnosis": [
            {
                "Mechanism": "KRAS G12C Inhibitors",
                "Medication": "Sotorasib",
                "Recommendations": [
                    "NCCN, Consensus, Non-Small Cell Lung Cancer",
                    "MSK OncoKB, Level 1"
                ],
                "Relevant Mutation": "KRASp.G12C G12C-GOF"
            }
        ],
        "Other Indications": [
            {
                "Mechanism": "KRAS G12C Inhibitors",
                "Medication": "Sotorasib",
                "Recommendations": [
                    "NCCN, Consensus, Non-Small Cell Lung Cancer",
                    "MSK OncoKB, Level 1"
                ],
                "Relevant Mutation": "KRASp.G12C G12C-GOF"
            }
        ]
    }
}